Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells

Daniele Vergara1, Concetta Maria Valente, Andrea Tinelli

  • 1Laboratory of General Physiology, Department of Biological and Environmental Sciences and Technologies, University of Salento, via Monteroni 73100, Lecce, Italy.

Cancer Letters
|July 29, 2011
PubMed

Insights

Resveratrol inhibits epidermal growth factor (EGF)-induced epithelial-to-mesenchymal transition (EMT) in MCF-7 cells. This natural compound blocks EGF’s effects on cell morphology, motility, and key EMT markers by inhibiting the ERK signaling pathway.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Carcinoma progression involves the loss of epithelial characteristics and the gain of a mesenchymal phenotype, a process known as epithelial-to-mesenchymal transition (EMT).
  • Epidermal growth factor (EGF) is a known inducer of EMT in various cancer cells.
  • Resveratrol, a natural stilbene, exhibits potential antitumor properties.

Purpose of the Study:

  • To investigate the effect of EGF on inducing EMT in MCF-7 cells.
  • To determine whether resveratrol can inhibit EGF-induced EMT.
  • To elucidate the signaling pathway involved in EGF-induced EMT and resveratrol's inhibitory mechanism.

Main Methods:

  • MCF-7 cells were treated with EGF alone or in combination with resveratrol.
  • Morphological changes, cell motility, and expression of EMT markers (Slug, Zeb1, Zeb2, Vimentin, N-cadherin) were assessed.
  • Specific chemical inhibitors were used to identify the involvement of the extracellular signal-regulated kinase 1/2 (ERK 1/2) pathway.

Main Results:

  • EGF treatment induced morphological changes, increased motility, and upregulated EMT markers in MCF-7 cells.
  • Combined treatment with EGF and resveratrol did not alter EGF-induced EMT.
  • EGF-induced EMT was mediated by the ERK 1/2 signaling pathway.
  • Resveratrol effectively repressed EGF-induced ERK activation.

Conclusions:

  • EGF induces EMT in MCF-7 cells via the ERK 1/2 signaling pathway.
  • Resveratrol inhibits EGF-induced EMT by repressing ERK 1/2 activation.
  • These findings highlight resveratrol's potential as an inhibitor of cancer cell transformation and progression.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.